Congress, Harvard, and Klausner

Favoritism alleged in $40 million contract, but former NCI chief says it's all innuendo

Ted Agres(tedagres@lycos.com)
Nov 12, 2003

In its continuing investigation into how the National Institutes of Health (NIH) awards research grants and contracts, the House Energy and Commerce Committee is seeking to determine whether Richard D. Klausner steered a $40 million contract to Harvard University while director of the National Cancer Institute (NCI) and during the time he was a candidate to become the school's president.

In a lengthy letter delivered this week to NIH, Harvard, and other organizations, Rep. Billy Tauzin (R-La.), committee chairman, and Rep. James Greenwood (R-Penn.), chairman of the Subcommittee on Oversight and Investigations, questioned “whether Harvard University received favorable treatment” in receiving funds in March 2002 to help create the school's Molecular Target Laboratory (MTL).

Klausner “appears to have personally and substantially participated in the MTL initiative that NCI awarded to Harvard University at a time when he had disqualified himself from personally and substantially participating in any matters affecting Harvard,”...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?